A Specific Tubular ApoA-I Distribution Is Associated to FSGS Recurrence after Kidney Transplantation

A major complication of primary focal segmental glomerulosclerosis (FSGS) is its recurrence after kidney transplantation that happens in 30 to 40% of the patients. The diagnosis of these relapses is not always easy as the histological lesions are not highly specific and appear after the proteinuria...

Full description

Bibliographic Details
Authors: Jacobs-Cachá, Conxita|||0000-0003-2518-7847, Puig-Gay, Natalia|||0000-0002-4703-0165, Vergara, Ander|||0000-0003-1926-0147, Gabaldon, Maria-Alejandra, Sellarés, Joana, Villena-Ortiz, Yolanda|||0000-0003-0925-0498, Agraz Pamplona, Irene|||0000-0002-4223-6834, Moreso, Francesc|||0000-0002-7267-3963, Soler, María José|||0000-0003-3621-0766, Seron, Daniel|||0000-0003-2054-653X, López-Hellín, Joan|||0000-0001-7286-3882
Format: article
Publication Date:2021
Country:España
Institution:Universitat Autònoma de Barcelona
Repository:Dipòsit Digital de Documents de la UAB
Language:English
OAI Identifier:oai:ddd.uab.cat:255654
Online Access:https://ddd.uab.cat/record/255654
https://dx.doi.org/urn:doi:10.3390/jcm10102174
Access Level:Open access
Keyword:Focal segmental glomerulosclerosis
FSGS
Recurrence
Apolipoprotein A-I
Apolipoprotein A-Ib
ApoA-I
ApoA-Ib
Biomarkers
Glomerular disease
Kidney transplantation
Description
Summary:A major complication of primary focal segmental glomerulosclerosis (FSGS) is its recurrence after kidney transplantation that happens in 30 to 40% of the patients. The diagnosis of these relapses is not always easy as the histological lesions are not highly specific and appear after the proteinuria increase. Currently, there are no accurate biomarkers to detect FSGS recurrence. Our group identified a modified form of Apolipoprotein A-I (ApoA-I), named ApoA-Ib, specifically present in the urine of recurrent FSGS patients after kidney transplantation. Aberrant forms of ApoA-I have also been described in the urine of native primary FSGS patients; this feature has been associated with prominent staining of ApoA-I at the apical membrane of the tubular cells. In this study, we aim to analyze the ApoA-I distribution in kidney allograft biopsies of recurrent FSGS patients. We detected ApoA-I by immunohistochemistry in kidney allograft biopsies of patients with FSGS relapse after kidney transplantation and in kidney allograft biopsies of patients with a disease different from FSGS in the native kidney (non-FSGS). In recurrent FSGS patients, ApoA-I was prominently localized at the brush border of the tubular cells, while in the non-FSGS patients, ApoA-I was found along the cytoplasm of the tubular cells. The localization of ApoA-I at the brush border of the tubular cells is a specific feature of primary FSGS in relapse. This suggests that ApoA-I staining in kidney biopsies, coupled with ApoA-Ib measurement in urine, could be used as a diagnostic tool of primary FSGS relapse after kidney transplantation due to its highly specific tubular distribution.